KMG Fiduciary Partners LLC Raises Stake in The Procter & Gamble Company (NYSE:PG)

KMG Fiduciary Partners LLC increased its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 17.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 78,024 shares of the company’s stock after buying an additional 11,489 shares during the period. Procter & Gamble comprises about 1.2% of KMG Fiduciary Partners LLC’s holdings, making the stock its 19th biggest position. KMG Fiduciary Partners LLC’s holdings in Procter & Gamble were worth $13,514,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in PG. Legacy Financial Group LLC purchased a new position in shares of Procter & Gamble in the first quarter worth about $270,000. Park Avenue Securities LLC grew its stake in Procter & Gamble by 10.7% in the 1st quarter. Park Avenue Securities LLC now owns 83,748 shares of the company’s stock valued at $13,588,000 after buying an additional 8,084 shares in the last quarter. Aprio Wealth Management LLC raised its holdings in Procter & Gamble by 12.8% during the 1st quarter. Aprio Wealth Management LLC now owns 6,027 shares of the company’s stock valued at $978,000 after acquiring an additional 683 shares during the period. Fragasso Group Inc. boosted its holdings in shares of Procter & Gamble by 1.9% in the first quarter. Fragasso Group Inc. now owns 11,143 shares of the company’s stock worth $1,808,000 after acquiring an additional 210 shares during the period. Finally, Triangle Securities Wealth Management grew its position in shares of Procter & Gamble by 3.5% in the first quarter. Triangle Securities Wealth Management now owns 15,947 shares of the company’s stock valued at $2,587,000 after purchasing an additional 540 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the business’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $76,149.00. Following the transaction, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Susan Street Whaley sold 450 shares of the business’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock worth $65,140,718 in the last three months. 0.18% of the stock is owned by insiders.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $171.28 on Friday. The firm has a fifty day simple moving average of $171.77 and a two-hundred day simple moving average of $167.11. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94. The company has a market capitalization of $404.23 billion, a PE ratio of 28.45, a P/E/G ratio of 3.74 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.83 EPS. Research analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s payout ratio is 66.94%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. BNP Paribas initiated coverage on Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective on the stock. Evercore ISI raised their price objective on shares of Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Piper Sandler assumed coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Finally, Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $176.21.

Check Out Our Latest Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.